AMG 557 is being investigated in Phase 1b for autoimmune illnesses such as for example systemic lupus erythematosus. AMG 157 is definitely a human monoclonal antibody that blocks conversation of thymic stromal lymphopoietin with the TSLP receptor. AMG 157 has been investigated in Phase 1b for asthma. About Amgen Amgen discovers, develops, manufactures and delivers innovative individual therapeutics. A biotechnology pioneer since 1980, Amgen was among the first companies to realize the new science’s guarantee by bringing effective and safe medicines from laboratory, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medication, helping millions of people all over the world in the fight cancer, kidney disease, rheumatoid arthritis, bone disease and additional serious illnesses.Dominic ffytcheExperimental drug candidate targeted at combating Alzheimer's disease offers anti-aging effectsLewy Body Composite Risk Rating detects LBD and Parkinson's disease dementia in 3 minutes The taskforce acknowledged that the healthcare provider makes the ultimate judgment regarding the care of each individual. The AIT sought to assist this process and identified the following general sequence of occasions for the usage of amyloid PET based on the new criteria: Evaluation by a dementia expert to assess the dependence on diagnostic testing, possibly to add amyloid Family pet if the AUC are met.